ClinicalTrials.Veeva

Menu

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

Boehringer Ingelheim logo

Boehringer Ingelheim

Status and phase

Completed
Phase 3

Conditions

Hypertension

Treatments

Drug: telmisartan
Drug: amlodipine
Drug: telmisartan and amlodipine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00860262
1235.20
2008-000873-40 (EudraCT Number)

Details and patient eligibility

About

The primary objective of this trial is to demonstrate that following eight weeks of treatment the FDC of telmisartan 80 mg plus amlodipine 10 mg (T80/A10) is superior as first line therapy in reducing mean seated trough cuff Systolic Blood Pressure [SBP] compared to the monotherapies of telmisartan 80 mg (T80) and amlodipine 10 mg (A10) in patients with severe hypertension. A key secondary objective is to identify the duration of treatment required to demonstrate the superiority of the FDC over both of the monotherapies.

Enrollment

858 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  1. Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation
  2. Age 18 years or older
  3. Patients with severe hypertension as defined SBP greater than 180 mmHg and DBP greater than 95 mmHg at randomisation
  4. Ability to stop any current antihypertensive therapy without unacceptable risk to the patient (Investigators discretion)

Exclusion criteria Mean in-clinic seated cuff SBP >/= 200 mmHg and/or Diastolic Blood Pressure [DBP] >/= 95 mmHg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

858 participants in 3 patient groups

telmisartan and amlodipine
Experimental group
Description:
telmisartan and amlodipine used in combination vs amlodipine or telmisartan
Treatment:
Drug: telmisartan and amlodipine
amlodipine
Active Comparator group
Description:
telmisartan and amlodipine used in combination vs amlodipine or telmisartan
Treatment:
Drug: amlodipine
telmisartan
Active Comparator group
Description:
telmisartan and amlodipine used in combination vs amlodipine or telmisartan
Treatment:
Drug: telmisartan

Trial contacts and locations

137

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems